Up to a third of ex-preterm infants flying near term exhibit pulse oxygen saturation (SpO 2 ) of less than 85% during air travel. A hypoxia challenge test (HCT) is recommended to evaluate the requirement for in-flight supplemental O 2 . The validity of the HCT in healthy, term infants has not been reported. This study aimed to characterise the in-flight hypoxia response and the accuracy of the HCT to predict this response in healthy, term infants in the first year of life. Infants (n=24: (15 male)) underwent a HCT prior to commercial air travel during which parents monitored SpO 2 . Thirty-two flights were undertaken with six infants completing multiple flights. The median in-flight SpO 2 nadir was 87% and significantly lower than the HCT SpO 2 nadir (92%: p<0.001). Infants on seven flights recorded SpO 2 <85% with one infant recording a HCT with a SpO 2 less than 85%. There was marked variability in the inflight SpO 2 in the six infants who undertook multiple flights, and for three of these infants, the SpO 2 nadir was both above and below 85%. We report that in healthy term infants an in-flight SpO 2 below 85% is common and can vary considerably between flights and that the HCT poorly predicts the risk of in-flight hypoxia (SpO 2 <85%). As it is common for healthy term infants to have SpO 2 less than 85% during air travel further research is needed to clarify whether this is an appropriate cut-off in this age group.
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Commercial aircrafts are pressurised to a maximum altitude of 2400 m during air travel resulting in a partial oxygen (O 2 ) pressure equivalent to 15-17% compared with 21% at sea level. 1 In healthy children and adults pulse oxygen saturation (SpO 2 ) declines to 89-94% during flight.
2 There are only limited reports of the in-flight hypoxia response in healthy infants.
The hypoxia challenge test (HCT) is used to evaluate the requirement for in-flight supplemental O 2 and involves monitoring SpO 2 while inhaling a fractional inspired O 2 concentration of ∼15%.
1 Preterm infants less than 1 year should use in-flight supplemental O 2 if the SpO 2 decreases to <85% during the HCT. 1 We have reported that preterm neonates flying near term exhibit hypoxia and that the HCT is unreliable. 3 The validity of the HCT in older infants has not been reported. This study aimed to characterise the in-flight hypoxia response and the accuracy of the HCT in healthy infants in the first year of life.
We recruited 24 healthy term infants (15 male) aged 2.3-44.6 weeks. Infants underwent a HCT 3 4 prior to commercial air travel. Parents monitored in-flight SpO 2 (WristOx 3100; Nonin, Minnesota, USA) and activity state. Ethical approval was received (Princess Margaret Hospital for Children Ethics Committee: 1533/EP) and written consent obtained.
Thirty-two flights were undertaken with six infants completing multiple flights. Activity was recorded in 26 (81%) flights with 14 infants being asleep and the remainder being awake with no differences in the in-flight SpO 2 nadir in sleeping infants compared with awake infants (data not shown). The median (range) HCT SpO 2 nadir was 92% (82-98%) with one infant recording a SpO 2 <85%. The median in-flight SpO 2 nadir was 87% (78-94%) and significantly lower than the HCT SpO 2 nadir (Wilcoxon signed rank test: p<0.001). Infants on 25 flights were classified as passing the HCT and maintaining their in-flight SpO 2 above 85%. Infants on seven flights (21.9%) recorded SpO 2 <85%, with only one infant recording a HCT with a SpO 2 <85%. There was marked in-flight SpO 2 variability in the six infants who undertook multiple flights (table 1) . One infant (infant 1) maintained SpO 2 >85% on two flights with the remaining infants recording SpO 2 nadirs from 78% to 90%. In this study, healthy term infants recorded in-flight SpO 2 below 85% in seven of 32 flights (22%).
In those infants with multiple flights, the SpO 2 nadir varied between flights and for three (50%) infants the SpO 2 nadir was both above and below 85%. Additionally, the HCT only correctly predicted one of seven infants as at risk for in-flight hypoxia (SpO 2 <85%). The impact of postnatal changes to oxygen transport through a reduction in oxygen affinity and oxygen carrying capacity 5 may play a role in the variable in-flight behaviour of young infants and further research should explore these changes. As it is common for healthy term infants to have SpO 2 less than 85% during air travel (without symptoms), further research clarifying the appropriateness of this cut-off is required.
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